Carlson Capital’s Cidara Therapeutics CDTX Stock Holding History

Carlson Capital’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,000	Closed	-$1.55M	–	74
2025 Q4	$1.55M	Buy	+7,000	New	+$1.13M	0.55%	17

Carlson Capital's CDTX Position: Q1 2026 in Review

Carlson Capital sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 7,000 shares — an estimated $1.55M sold.

Carlson Capital first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $1.55M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Carlson Capital reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Carlson Capital sold 7,000 Cidara Therapeutics shares in Q1 2026, an estimated $1.55M.
Carlson Capital first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Carlson Capital's Cidara Therapeutics position peaked at $1.55M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Carlson Capital's 13F filing for Q1 2026, filed 28 May 2026.